{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:21:54Z","timestamp":1706574114192},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Management of the enhanced-fibrinolytic type of disseminated intravascular coagulation (DIC) caused by aortic disorders is the two strategies of surgical intervention and medical treatment based on the patient\u2019s age and comorbidities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>An 81-year-old woman with a history of two previous aortic surgeries and chronic heart and renal failure was admitted for uncontrollable subcutaneous hemorrhage. The hemorrhage was caused by the enhanced-fibrinolytic type of disseminated intravascular coagulation (DIC) caused by periprosthetic graft hematoma after aortic replacement for Stanford type A aortic dissection. Open thoracic hemostasis temporarily controlled the subcutaneous hemorrhage, but she was readmitted for the recurrence seven months after discharge. On the second admission, the combination of anticoagulant and antifibrinolytic agents was successful.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Management of the enhanced-fibrinolytic type of DIC caused by aortic disorders is important of a successful combination of surgical and medical therapy tailored the patient\u2019s condition.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-024-03750-0","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T09:03:44Z","timestamp":1706519024000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The two therapeutic strategies of surgical intervention and medical management in a patient with enhanced-fibrinolytic type of disseminated intravascular coagulation after aortic replacement for Stanford type A aortic dissection with chronic heart and renal failure"],"prefix":"10.1186","volume":"24","author":[{"given":"Hiroki","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"key":"3750_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2052-0492-2-15","volume":"2","author":"H Wada","year":"2014","unstructured":"Wada H, Matsumoto T, Yamashita Y. Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. J Intensive Care Med. 2014;2:15.","journal-title":"J Intensive Care Med"},{"key":"3750_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1365-2141.2009.07600.x","volume":"145","author":"M Levi","year":"2009","unstructured":"Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol. 2009;145:24\u201333.","journal-title":"Br J Haematol."},{"key":"3750_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/2052-0492-2-20","volume":"2","author":"H Asakura","year":"2014","unstructured":"Asakura H. Classifying types of disseminated intravascular coagulation clinical and animal models. J Intensive Care Med. 2014;2:20.","journal-title":"J Intensive Care Med"},{"key":"3750_CR4","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.2169\/internalmedicine.54.4942","volume":"54","author":"H Kawano","year":"2015","unstructured":"Kawano H, Hata T, Uda A, Maemura K. Use of rivaroxaban for the effective management of disseminated intravascular coagulation associated with abdominal aortic aneurysm. Intern Med. 2015;54:2625\u20138.","journal-title":"Intern Med"},{"key":"3750_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11684-017-0498-7","volume":"11","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Li C, Shen M, Liu B, Zeng X, Shen T. Aortic aneurysm and chronic disseminated intravascular coagulation: a retrospective study of 235 patients. Front Med. 2017;11:62\u20137.","journal-title":"Front Med"},{"key":"3750_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2169\/internalmedicine.46.6155","volume":"46","author":"S Miyahara","year":"2007","unstructured":"Miyahara S, Yasu T, Yamada Y, Kobayashi N, Saito M, Momomura S-I. Subcutaneous injection of heparin calcium controls chronic disseminated intravascular coagulation associated with inoperable dissecting aortic aneurysm in an outpatient clinic. Intern Med. 2007;46:727\u201332.","journal-title":"Intern Med"},{"key":"3750_CR7","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.athoracsur.2008.10.033","volume":"88","author":"K Yamamoto","year":"2009","unstructured":"Yamamoto K, Ito H, Hiraiwa T, Tanaka K. Effects of nafamostat mesilate on coagulopathy with chronic aortic dissection. Ann Thorac Surg. 2009;88:1331\u20133.","journal-title":"Ann Thorac Surg"},{"key":"3750_CR8","first-page":"30","volume":"42","author":"K Yoneda","year":"2001","unstructured":"Yoneda K, Amano I, Tanaka H, et al. Effective use of camostat mesilate for chronic disseminated intravascular coagulation complicated by thoracoabdominal aortic aneurysm. Rinsho Ketsueki. 2001;42:30\u20134.","journal-title":"Rinsho Ketsueki"},{"key":"3750_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2169\/internalmedicine.53.1201","volume":"53","author":"T Hasebe","year":"2014","unstructured":"Hasebe T, Sawada K, Nakajima S, et al. Effective control of relapsing disseminated intravascular coagulation in a patient with decompensated liver cirrhosis by recombinant soluble thrombomodulin. Intern Med. 2014;53:29\u201333.","journal-title":"Intern Med"},{"key":"3750_CR10","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.2169\/internalmedicine.8666-16","volume":"56","author":"Y Kadohira","year":"2017","unstructured":"Kadohira Y, Yamada S, Matsuura E, et al. Aortic Aneurysm-associated Disseminated Intravascular Coagulation that Responded Well to a Switch from Warfarin to Rivaroxaban. Intern Med. 2017;56:2913\u20137.","journal-title":"Intern Med"},{"key":"3750_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s12185-009-0309-2","volume":"89","author":"S-I Kimura","year":"2009","unstructured":"Kimura S-I, Odawara J, Aoki T, et al. Use of tranexamic acid for disseminated intravascular coagulation with excessive fibrinolysis associated with aortic dissection in a patient with chronic renal failure. Int J Hematol. 2009;89:549\u201352.","journal-title":"Int J Hematol"},{"key":"3750_CR12","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2169\/internalmedicine.56.7499","volume":"56","author":"Y Gatate","year":"2017","unstructured":"Gatate Y, Masaki N, Sato A, et al. Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years. Intern Med. 2017;56:925\u20139.","journal-title":"Intern Med"},{"key":"3750_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.14740\/jmc3549","volume":"11","author":"PL Yip","year":"2020","unstructured":"Yip PL, Lau SMJ, Lee TYJ. Severe Bleeding Tendency due to Excessive Fibrinolysis in Two Patients With Aortic Disease: Role of Tranexamic Acid in Non-Surgical Candidate. J Med Cases. 2020;11:303\u20135.","journal-title":"J Med Cases"},{"key":"3750_CR14","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1056\/NEJM199904013401303","volume":"340","author":"JS Menell","year":"1999","unstructured":"Menell JS, Cesarman GM, Jacovina AT, McLaughlin MA, Lev EA, Hajjar KA. Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med. 1999;340:994\u20131004.","journal-title":"N Engl J Med"},{"key":"3750_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12959-022-00429-4","volume":"21","author":"N Suzuki","year":"2023","unstructured":"Suzuki N, Suzuki N, Kawaguchi Y, et al. The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of 14 patients. Thromb J. 2023;21:10.","journal-title":"Thromb J"},{"key":"3750_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1254\/fpj.88.449","volume":"88","author":"Y Ino","year":"1986","unstructured":"Ino Y, Suzuki K, Sato T, Iwaki M. Comparative studies of nafamostat mesilate and various serine protease inhibitors in vitro. Nihon Yakurigaku Zasshi. 1986;88:449\u201355.","journal-title":"Nihon Yakurigaku Zasshi"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-03750-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-03750-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-03750-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T21:27:18Z","timestamp":1706563638000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-03750-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3750"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-03750-0","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,29]]},"assertion":[{"value":"26 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s family for publication of this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}